Showing results (101-110 of 179) with videos related to
Sort By:
Pageof 18
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 27, 2000
Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skinJ Berger, A Telser, M Widschwendter, et al.Gynakologisch-Geburtshilfliche Rundschau|October 10, 2002
[The evaluation of the second-look operation of patients with ovarian carcinoma and tubal carcinoma by means of a retrospective comparison study]H W Ott, K Illmensee, A Zeimet, et al.Anticancer Research|July 1, 1997
Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cellsA G Zeimet, F A Offner, C Marth, et al.Gynecologic Oncology Reports|August 28, 2023
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case reportM Lehmann, H Hosa, T Bartl, et al.British Journal of Cancer|January 1, 1997
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancerA G Zeimet, M Widschwendter, M Uhl-Steidl, et al.Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Immunostimulating protein 90K in ovarian carcinoma]A G Zeimet, C Marth, D Fuchs, et al.Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Relationship between quantity of silver stained nucleolar organizer region associated proteins (Ag-NORs) and growth rate suppression of breast cancer cell lines after interferon-gamma and 4-hydroxy-tamoxifen treatmentD Ofner, A Hittmair, C Marth, et al.Gynecologic Oncology|January 1, 1997
Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometriumC Marth, G Windbichler, E Petru, et al.Geburtshilfe Und Frauenheilkunde|August 1, 1992
[Magnetic resonance tomography in follow-up of hydatidiform mole]C Marth, W Judmaier, G Helweg, et al.Geburtshilfe Und Frauenheilkunde|May 1, 1993
[The value of etoposide (VP-16) in the therapy of refractory ovarian cancer]C Marth, E Pointner, A G Zeimet, et al.Pageof 18